Safety of PCI-32765 in Chronic Lymphocytic Leukemia

Clinical trial NCT01105247 · COMPLETED

Trial details

NCT number: NCT01105247
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Start date: 2010-05-01
Primary completion: 2012-12-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.